Provided by Tiger Trade Technology Pte. Ltd.

10x Genomics, Inc.

19.81
+0.67003.50%
Post-market: 19.75-0.0600-0.30%19:46 EDT
Volume:1.60M
Turnover:31.46M
Market Cap:2.53B
PE:-56.75
High:19.90
Open:18.78
Low:18.77
Close:19.14
52wk High:23.56
52wk Low:6.78
Shares:127.69M
Float Shares:115.00M
Volume Ratio:0.65
T/O Rate:1.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3490
EPS(LYR):-0.3490
ROE:-5.78%
ROA:-6.40%
PB:3.18
PE(LYR):-56.75

Loading ...

10x Genomics Cut to Equal-Weight From Overweight by Morgan Stanley

Dow Jones
·
Dec 02, 2025

Morgan Stanley Downgrades 10x Genomics to Equalweight From Overweight, Lifts Price Target to $20 From $17

MT Newswires Live
·
Dec 02, 2025

10x Genomics (TXG) Is Up 19.8% After Pan-Cancer Atlas Collaboration With Garvan and University of Tokyo

Simply Wall St.
·
Nov 27, 2025

Will 10x Genomics' (TXG) Role in ASTRA Shift Its Competitive Edge in Precision Oncology?

Simply Wall St.
·
Nov 20, 2025

10x Genomics Joins Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas

Reuters
·
Nov 18, 2025

10x Genomics Appoints Randy Wu as General Counsel Replacing Eric Whitaker

Reuters
·
Nov 14, 2025

10x Genomics to Join Wolfe Research Healthcare Conference

Reuters
·
Nov 12, 2025

10x Genomics Is Maintained at Neutral by Piper Sandler

Dow Jones
·
Nov 12, 2025

10x Genomics (TXG): How Fresh Results and New Guidance Are Shaping Its Valuation

Simply Wall St.
·
Nov 08, 2025

UBS Adjusts Price Target on 10x Genomics to $14 From $13, Maintains Neutral Rating

MT Newswires Live
·
Nov 08, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Novo Nordisk, Block, Peloton Interactive

Reuters
·
Nov 08, 2025

Stifel Nicolaus Sticks to Their Buy Rating for 10x Genomics (TXG)

TIPRANKS
·
Nov 07, 2025

Stock Track | 10x Genomics Soars 13.88% on Strong Q3 Results, Upbeat Q4 Outlook, and Analyst Upgrades

Stock Track
·
Nov 07, 2025

10x Genomics Is Maintained at Overweight by Barclays

Dow Jones
·
Nov 07, 2025

BUZZ-U.S. STOCKS ON THE MOVE-ANI Pharmaceuticals, Wendy's, nLIGHT

Reuters
·
Nov 07, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, gold and silver miners

Reuters
·
Nov 07, 2025

10x Genomics price target raised to $19 from $16 at Canaccord

TIPRANKS
·
Nov 07, 2025

Stock Track | 10x Genomics Soars 13.38% Pre-market on Strong Q3 Results, Upbeat Q4 Outlook, and Analyst Upgrades

Stock Track
·
Nov 07, 2025

BUZZ-10x Genomics jumps after forecasting Q4 revenue above estimates

Reuters
·
Nov 07, 2025

10x Genomics Shares up 11.6% Premarket After Q3 Revenue Beat Estimates, Net Loss Narrows

THOMSON REUTERS
·
Nov 07, 2025